|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| A61K 31/44 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| C07D 213/74 | (2006.01) | ||
| C07D 213/89 | (2006.01) |
| (11) | Number of the document | 2785706 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12798549.7 |
| Date of filing the European patent application | 2012-11-28 | |
| (97) | Date of publication of the European application | 2014-10-08 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-14 |
| (46) | Date of publication of the claims translation | 2016-12-12 |
| (86) | Number | PCT/US2012/066778 |
| Date | 2012-11-28 |
| (87) | Number | WO 2013/082102 |
| Date | 2013-06-06 |
| (30) | Number | Date | Country code |
| 201161564537 P | 2011-11-29 | US | |
| 201213478361 | 2012-05-23 | US |
| (72) |
FADINI, Luca, CH
MANINI, Peter, CH
PIETRA, Claudio, IT
GIULIANO, Claudio, IT
LOVATI, Emanuela, CH
CANNELLA, Roberta, IT
VENTURINI, Alessio, IT
STELLA, Valentino, J., US
|
| (73) |
Helsinn Healthcare SA,
Via Pian Scairolo 9, 6912 Lugano-Pazzallo,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui |
| SUBSTITUTED 4-PHENYL-PYRIDINES FOR THE TREATMENT OF NK-1 RECEPTOR RELATED DISEASES. |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 14 | 289.00 EUR |
| 2026-11-28 |